Home » Authors » James Etheridge

Articles by James Etheridge

GenOway Signs 2 Agreements to Provide Mouse-Rat Lines

April 9, 2008

By James Etheridge

BioAlliance, Handok Team for Loramyc Distribution

April 2, 2008

By James Etheridge

Mapreg Gets Orphan Status for Spinal Cord Injury Drug

March 26, 2008

By James Etheridge

Cellectis in Suit with Precision for Patent Infringement

March 19, 2008

By James Etheridge

TxCell Completes €10.5M Round and Begins First Clinical Trial

March 12, 2008

By James Etheridge

No Abstract

Trophos Gets $1.4M Grant to Validate Drug in IRI

March 5, 2008

By James Etheridge

NicOx Begins Osteo Trials of Anti-Inflammatory Naproxcinod

March 5, 2008

By James Etheridge

NicOx Begins Osteo Trials of Anti-Inflammatory Naproxcinod

March 5, 2008

By James Etheridge

Trophos Gets $1.4M Grant to Validate Drug in IRI

March 5, 2008

By James Etheridge

Immtech Drops Pafuramidine Due to Liver Safety Concerns

Feb. 27, 2008

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...